Zu "1072833-77-2" wurden 4 Artikel gefunden!

Für die Filterung wurden keine Ergebnisse gefunden!
Ixazomib
Ixazomib

Artikelnummer: TGM-T2122-100mg

Description: Ixazomib (MLN2238) , a second generation, boron-containing peptide proteasome inhibitor (PI), inhibits the chymotrypsin-like proteolytic (beta5) site of the 20S proteasome (IC50/Ki: 3.4/0.93 nM, in cell-free assays), also inhibits the caspase-like (beta1) and trypsin-like (beta2) proteolytic sites...
Schlagworte: MLN2238
CAS 1072833-77-2
MW: 361.03 D
ab 41,00 €
Bewerten
Ixazomib [MLN2238]
Ixazomib [MLN2238]

Artikelnummer: AG-CR1-3670-M001

Synthetic. Chemical. CAS: 1072833-77-2. Formula: C14H19BCl2N2O4. MW: 361. Synthetic. Potent selective and reversible proteasome inhibitor (all proteolytic subunits). Targets the chymotrypsin-like beta5 subunit of the constitutive 20S proteasome (IC50=3.4nM). Cross-reacts and inhibits the trypsin-like beta2 subunit...
Schlagworte: (R)-1-(2-(2,5-Dichlorobenzamido)acetamido)-3-methylbutylboronic acid
Anwendung: Proteasome inhibitor
CAS 1072833-77-2
MW: 361 D
ab 44,00 €
Bewerten
MLN-2238
MLN-2238

Artikelnummer: LKT-M4455.1

MLN-2238 is a proteasome inhibitor that modulates miR33b, a tumor suppressor microRNA. MLN-2238 exhibits anticancer activity, downregulating Pim-1 activity in multiple myeloma cells.
Schlagworte: Ixazomib
Anwendung: Proteasome subunit beta type-5 inhibitor
CAS 1072833-77-2
MW: 361.03 D
ab 77,00 €
Bewerten
MLN2238
MLN2238

Artikelnummer: Cay18385-10

MLN2238 is an inhibitor of the beta5 subunit of the 20S proteasome (IC50 = 3.4 nM in a cell-free assay) and an active metabolite of MLN9708 (Cay-18386). It is formed from MLN9708 via hydrolysis in plasma. MLN2238 is selective for the chymotrypsin-like beta5 subunit over the caspase-like beta1 and trypsin-like beta2...
Schlagworte: B-[(1R)-1-[[2-[(2,5-dichlorobenzoyl)amino]acetyl]amino]-3-methylbutyl]-boronic acid
Anwendung: Proteasome PSMB5 inhibitor
CAS 1072833-77-2
MW: 361 D
ab 46,00 €
Bewerten